Quote Originally Posted by Daly View Post
Quote Originally Posted by OSA View Post


I got fucked from SAVA when I invested in their opiod recovery addiction drug/treatment that failed. I hate these bio stocks but whatever, Ill gamble.

Look I’m bullish - but big difference between Being long at .60 or $2.75 when the stock is now trading with a 7 handle though. Even with bad news there is a shot I can get out semi unscathed..... not the same when you holding at $7.25.

It’s priced at roughly $4B right now with a share price of $7. This thing has been bought in large blocks around the clock for the past week. Id be genuinely surprised if we get bad news on this one anytime soon - but as you said biotech can turn on a dime. So like I said $4B company. Mondera went from a $7B company at ~$20 a share to 30B company at ~$90 a share on some half assed drug that there is major debate on if it works or not. There are some that say this may be the best CC5 blocker ever and early tests have been greatly positive. Like take some and come off the ventilator in 48 hours type stuff with no side effects. So the crazy kool aide take here is if we get an official trial with the same results and the FDA says move forward and you on the top of the list fast track and Trump gives this a mention as a life saving treatment for COVID dejour...... this could literaly go parabolic to $70 ($40B) a share.

That’s a stright up pie in the sky kool aide drinking Result and I’m not in any way calling for that..... but it’s not imposible either.

Or I could be begging by a dumpster when this goes pop.
I don't know why you're dismissing Moderna. Their vaccine has been showing promise and the US Gov't dumped them $500 million. Seems like a little more than a half-assed drug.

I read a few articles about the CYDY and it does sound like they have a few things on the go, not just Covid.

  • Coronavirus results to be reported in July. Anecdotal results are excellent.
  • HIV results are excellent. BLA has been applied for.
  • 12 ladies with triple negative breast cancer have seen their CTCs (circulating tumor cells) go to zero in 3 to 6 weeks with a once a week injection.
  • A basket cancer trial of 22 different cancers is in the works to test the hypothesis that metastasis can be stopped in cancers expressing CCR5 receptor.
  • Animal testing for multiple sclerosis was very favorable. NASH and GvH also being pursued. And a 400-patient trial of Alzheimer's is also in the works.